Follow the event on twitter #IGBAMedicinesforEU

Lucia Romagnoli - T: +44-7562-876873 - E: events@medicinesforeurope.com

www.medicinesforeurope.com/events

PROGRAMME

Patients

increasing patient

access

Quality

quality, safety and

efficacy

Value

investors in

innovation

Sustainability

160.000 jobs across

Europe

Partnership

key partners for

public health

Wednesday 14 June

16:30

-

18:30

--PRICING & REIMBURSEMENT--

Pre-Conference Workshop 1: Pricing and Reimbursement Policies around Generic Medicines

Chair | Michele Uda, Director General – Assogenerici and Chair EMAC – Medicines for Europe

Panel

Helder Mota-Filipe, Associate Professor of Faculty of Pharmacy, University of Lisbon and former

Member of the Executive Board – National Authority of Medicines and Health Products (Infarmed

I.P.)

Jaime Espin, Professor – Andalusian School of Public Health

Giovanni Tafuri, Senior HTA Officer – Italian Medicines Agency (AIFA)

Németh Gergely, Project Manager – National Health Insurance Fund of Hungary (OEP)

Victor Lino Mendonça, Head of Policy and Market Access Europe – Mylan

16:30

-

18:30

--ETHICS--

Pre-Conference Workshop 2: International Consensus Framework on Ethics in the Healthcare Sector

Chair | Michael Fadus, Vice President of Compliance – Teva

Panel

Ema Paulino, Professional Secretary FIP Executive Committee and President Lisbon and South

Branch of the Portuguese Pharmaceutical Society

Robert Andrew Johnstone, Patient Advocate

Christophe Lesguer, CCO, Chief Compliance Officer Europe – Mylan GmbH

Heikki Pälve, CEO – Finnish Medical Association

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

16:30

-

18:30

--COMMUNICATIONS--

Pre-Conference Workshop 3: #AccessHealth, what’s behind a hashtag?

Chair | John Gisborne, Managing Director and Senior Partner – FleishmanHillard Fishburn

Panel

Aidan Fry, Editor – Generics Bulletin

Paul Tunnah, CEO and Founder – Pharmaphorum

Laetitia Tonel, Head of Communications – Mylan Europe

Chris Lewis, Senior Manager External Communications – Sandoz Global Communications

James Duggan, Principal Medical Writer – 90TEN/IGBA Biosimilar Medicines Communication Project

Evan O’Connell, Communications and Public Affairs Specialist – Aspect Consulting

16:30

-

18:30

--TRADE--

Pre-Conference Workshop 4: Business Opportunities in External Markets and Access to Medicines –

An Assessment of the International Affairs Committee

Chair | Sergio Napolitano, Legal and External Relations Director – Medicines for Europe

Panel

Alan Sheppard, Principal, Global Generics and Biosimilars, Thought Leadership – QuintilesIMS

Alejandro Ollé, Partner and Co-founder – Galenicum

David Jauch, Senior Manager Global Regulatory Affairs, Government Relations – Fresenius Kabi

Oleh Syarkevych, Business Development Director – Farmak JSC

Natalia Matting, Lawyer – DG Trade, European Commission

Koen Nauwelaerts, Quality and Regulatory Manager – Medicines for Europe

20:00

Welcome Cocktail sponsored by and Conference Registrations

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

Thursday 15 June

08:00

Welcome Coffee and Registration

09:00

--OPENING ADDRESS--

Jacek Glinka, President – Medicines for Europe

--OPENING KEYNOTE SPEECH--

Maria do Céu Machado, President – INFARMED

09:30

--SUSTAINABILITY--

Better Access, Better Health: our Industry’s Vision on Sustainability of Healthcare

Chair | Adrian van den Hoven, Director General – Medicines for Europe

Panel

Rabia Khan, Health Policy Analyst – OECD

Christa Cepuch, Pharmacist Coordinator – MSF Access Campaign

Alex Harris, CEO – International Health Partners

Robert Andrew Johnstone, Patient Advocate

Pierluigi Antonelli, Head Western Europe – Sandoz International

Jacek Glinka, President Europe – Mylan

11:00

Networking Coffee break

11:40

--DEVELOPED MARKETS--

Global Update of Generic Medicines in Developed Markets

Chair | Jim Keon, President – Canadian Generic Pharmaceutical Association and President, Biosimilars

Canada

Panel

Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS

Kyozo Inari, Executive Corporate Officer – Sawai Pharmaceutical Co., Ltd. and Chair of International

Affairs Committee – JGA

John McCullough, VP Commercial Generics Europe and Global In Line Portfolio Management – Teva

Tony Mauro, Chief Commercial Officer – Mylan

13:00

Networking Buffet Lunch sponsored by

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

14:00

--GLOBAL MANUFACTURING--

Making Generic and Biosimilar Manufacturing

Thrive: A Global Policy

Chair | Michele Uda, Director General –

Assogenerici and Chair EMAC – Medicines for

Europe

Panel

Gian Mario Baccalini, President –

Aschimfarma and Chair – European Fine

Chemicals Group

Dinesh Dua, Vice Chairman –

Pharmaceuticals Export Promotion

Council of India

Satoshi Kawamura, Senior Vice

President – Nipro Pharma Corporation

Jody Cox, Vice President Federal and

International Affairs, Canadian Generic

Pharmaceutical Association and Vice

President, Biosimilars Canada

--PROCUREMENT--

A Concerted Approach to Tackle Economic and

Regulatory Aspects of Shortages

Chair | Marc-Alexander Mahl, Executive Vice President,

Business Unit Generic Drugs – Fresenius Kabi and Chair

of the Hospital Working Group – Medicines for Europe

Panel

Annie Pannelay, Principal – The Economist

Intelligence Unit

Maggie Dolan, Regional Pharmacy Procurement

Specialist – NHS Commercial Solutions Surrey

Aida Batista, Board Member, Director of

Professional Development – European Association

of Hospital Pharmacists

Marcel T. M. van Raaij, Director Ministry of

Health – The Netherlands

Dominik Tomek, Board Member – European

Patients Forum

Yi-Yun (April) Wang, Legal Manager - Yung Shin

Pharm. Ind. Co., Ltd. and Chair, International

Affairs Committee – Taiwan Generic

Pharmaceutical Association

15:20

Networking Coffee Break

16:00

--INTERNATIONAL CONVERGENCE--

International Regulatory and Supply Chain

Cooperation

Chair | David Gaugh, Senior Vice President,

Sciences and Regulatory Affairs – AAM

Panel

Sabine Kopp, Group Lead, Medicines

Quality Assurance – WHO

Brendan Cuddy, Head of Manufacturing

and Quality Compliance – EMA

Nuala Calnan, Senior Associate –

Lachman Consultant Services, Inc.

Mechthild Sander, Qualified Person –

Alfred E. Tiefenbacher

--VALUE ADDED MEDICINES--

A New Value Proposition for Patients, Healthcare

Practitioners and Systems

Chair | Christoph Stoller, SVP, Chief Operating Officer

GGM Europe – Teva Pharmaceuticals Europe B.V. and

Vice-President – Medicines for Europe

Panel

Mondher Toumi, Professor – University of Aix-

Marseille

Robert Andrew Johnstone, Patient Advocate

Sampreet Ramachandra, Director of Strategy –

Fresenius Kabi

Antonio Vaz Carneiro, Head – Centre for

Evidence-Based Medicine (CEMBE) - Faculty of

Medicine of the University of Lisbon

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

17:20

-

18:30

--WOMEN’S LEADERSHIP & PHARMA

Interactive session: Q&A with influential women in healthcare

Chair | Hanan J. Sboul, Secretary General – Jordanian Association of Pharmaceutical Manufacturers

Panel

Carol Lynch, Global Head of Biopharmaceuticals – Sandoz / Chair of the Biosimilar Medicines Group

Catarina Nobre, President – EPSA

Elisabeth Stampa, CEO – Medichem SA

Suzette Kox, Senior Director International – Biosimilar Medicines Group

Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia and Vice-Chair

of the IGBA Biosimilars Committee

19:30

Conference Dinner sponsored by

Friday 16 June

08:00

Networking Coffee

09:00

--OPENING ADDRESS—

Paulo Lilaia, President – Apogen (Portuguese Association for Generic and Biosimilar Medicines)

--OPENING SPEECH—

José Inácio Faria, MEP – EPP Portugal

09:20

--BUSINESS--

A Discussion with the Global Leaders and Analysts

Chair | John Hodgson, Executive Editor – In Vivo, Informa Pharma Intelligence Group

Panel

Elisabeth Stampa, CEO – Medichem

Enrique Ordieres, President – Cinfa

Jeremy B. Desai, CEO – Apotex Inc.

Frances Cloud, Founder – Pharmacloud

Randall Stanicky, Managing Director – RBC Capital Markets

Simon Goeller, Partner – McKinsey & Company

10:40

Networking Coffee Break

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

11:30 --EMERGING MARKETS—

Unlocking Pharma Growth – Emerging Markets

Chair | Rafael Enrique Maciel Martínez, President – AMEGI

Panel

Jean Mina, Associate Partner – McKinsey & Company

Abdallah Mazahreh, Marketing Director / MENA & Emerging Markets – Pharma International

Company

Vivian Frittelli, CEO – NAPM (South Africa)

Dilip G Shah, Secretary General – IPA (South Asia and India)

Keh Song Hock, Executive Director – Malaysian Organisation of Pharmaceutical Industries (Southeast

Asia)

Talgat Nurgozhin, Director – Center for Life Sciences, “National Laboratory “Astana”, Nazarbayev

University (Central Asia and Eastern Europe)

12:45

Networking Buffet Lunch sponsored by

14:00

--BIOSIMILAR MEDICINES--

Global Market Policies for Biosimilar Medicines

Chair | Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia

and Vice-Chair of the IGBA Biosimilars Committee

Panel

Maggie Dolan, Regional Pharmacy Procurement Specialist – NHS Commercial Solutions Surrey

Gillian Woollett, Senior Vice President – Avalere Health

Suzanne McGurn, Assistant Deputy Minister (ADM) and Executive Officer (EO) – Ontario Public Drug

Programs

Hiroyuki Sakamaki, Professor – Tokyo University of Science

Florian Turk, Global Head Payor Marketing, Sales and Engagement – Sandoz and Vice-Chair of the

Market Access Committee of the Biosimilar Medicines Group, a Medicines for Europe Sector Group

15:20

--CLOSING REMARKS--

Adrian van den Hoven, Chairman – IGBA

Please note that there will be simultaneous translation

English-Portuguese available.

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

SPONSORS

MEDIA PARTNERS